← Back
Cavalieri II Room
December, 01st | 15:20 - 15:56
TECHNOLOGICAL AND DRUG DEVELOPMENTS BY CLINICIANS AND RESEARCHERS
Add to calendar
Chairs: AWH CARL, BRUCKER ALEXANDER J., RIZZO STANISLAO
December, 01st | 15:20 - 15:26
Liposomal ozonated oil associated with PI 5% ensures a further reduction in the microbial load compared to PI 5% alone before IVT: The “OPERA study”
BOSCIA FRANCESCO, GRASSI MARIA OLIVA
Add to calendar
Liposomal ozonated oil associated with PI 5% ensures a further reduction in the microbial load compared to PI 5% alone before IVT: The “OPERA study”
BOSCIA FRANCESCO, GRASSI MARIA OLIVA
Add to calendar
December, 01st | 15:26 - 15:32
Vitreous Bioavailability and Anti-inflammatory Action of Associated Active Principles administered per os: The multicentric “VIBIA study”
VENTRE LUCA
Add to calendar
Vitreous Bioavailability and Anti-inflammatory Action of Associated Active Principles administered per os: The multicentric “VIBIA study”
VENTRE LUCA
Add to calendar
December, 01st | 15:32 - 15:38
ChatOCT – AI and digitalization
NICOLETTI MANLIO, MOLLE ANDREA
Add to calendar
ChatOCT – AI and digitalization
NICOLETTI MANLIO, MOLLE ANDREA
Add to calendar
December, 01st | 15:38 - 15:44
A new concept: Diabetic Retinopathy as Neurovascular disease?
BOSCIA FRANCESCO
Add to calendar
A new concept: Diabetic Retinopathy as Neurovascular disease?
BOSCIA FRANCESCO
Add to calendar
December, 01st | 15:44 - 15:50
New frontiers for treatment of patients with early stage Diabetic Retinopathy: clinical evidences with eye drops
BANDELLO FRANCESCO
Add to calendar
New frontiers for treatment of patients with early stage Diabetic Retinopathy: clinical evidences with eye drops
BANDELLO FRANCESCO
Add to calendar
December, 01st | 15:50 - 15:56
Innovation in Tyrosine Kinase Inhibition for Retinal Vascular Diseases
MOSHFEGHI ANDREW
Add to calendar
Innovation in Tyrosine Kinase Inhibition for Retinal Vascular Diseases
MOSHFEGHI ANDREW
Add to calendar
